7 unknown. 7 Phase 1, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 7 | Unknown 7 |
| Phase 2 | 3 | Unknown 3 |
Follow Oligodendroglioma: new trials by email Literature Review of Oligodendroglioma trials Research Report on Oligodendroglioma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of 131I-TM601 in Adults With Recurrent Malignant Glioma 131I-TM601 - Malignant Glioma, Glioblastoma Multiforme | Phase 1 / Phase 2 | Unknown | TransMolecular | 64 | 2008-08-01 | 2009-07-17 |
| Safety and Dose-Finding Study of TM-601 in Adults With Recurrent Malignant Glioma TM-601 - Malignant Glioma, Glioblastoma Multiforme | Phase 1 | Unknown | TransMolecular | 36 | 2008-02-01 | 2009-07-17 |
| Enzastaurin and Temozolomide in Treating Patients With Primary Gliomas enzastaurin hydrochloride, temozolomide, pharmacological study - Brain and Central Nervous System Tumors | Phase 1 | Unknown | European Organisation for Research and Treatment of Cancer - EORTC | 28 | 2007-07-01 | 2015-02-10 |
| Arsenic Trioxide, Temozolomide, and Radiation Therapy in Treating Patients With Malignant Glioma That Has Been Removed By Surgery arsenic trioxide, temozolomide, radiation therapy - Brain and Central Nervous System Tumors | Phase 1 / Phase 2 | Unknown | Northwestern University | 50 | 2005-05-01 | 2020-02-25 |
| Lonafarnib and Temozolomide in Treating Patients With Recurrent Primary Supratentorial Gliomas lonafarnib, temozolomide - Brain and Central Nervous System Tumors | Phase 1 | Unknown | European Organisation for Research and Treatment of Cancer - EORTC | 30 | 2004-03-01 | 2015-02-10 |
| Carmustine Followed By Surgery in Treating Patients With Recurrent Supratentorial Malignant Glioma or Metastatic Brain Neoplasm carmustine in ethanol, conventional surgery - Brain and Central Nervous System Tumors, Metastatic Cancer | Phase 1 / Phase 2 | Unknown | Direct Therapeutics | 2000-06-01 | 2013-11-06 | |
| Photodynamic Therapy With Porfimer Sodium in Treating Patients With Refractory Brain Tumors verteporfin, conventional surgery - Brain and Central Nervous System Tumors, Metastatic Cancer | Phase 1 | Unknown | Medical College of Wisconsin | 24 | 1994-05-01 | 2013-09-20 |
Astrocytoma (7) · Brain Neoplasms (7) · Glioblastoma (7) · Central Nervous System Neoplasms (5) · Glioma (5) · Gliosarcoma (5) · Ependymoma (4) · Glioma, Subependymal (2) · Neoplasm Metastasis (2) · Choroid Plexus Neoplasms (1) · Craniopharyngioma (1) · Familial ependymoma (1) · Medulloblastoma (1) · Meningioma (1)
Brain Diseases (7) · Central Nervous System Diseases (7) · Neoplasms (7) · Neoplasms by Histologic Type (7) · Neoplasms by Site (7) · Neoplasms, Germ Cell and Embryonal (7) · Neoplasms, Glandular and Epithelial (7) · Neoplasms, Nerve Tissue (7) · Nervous System Diseases (7) · Nervous System Neoplasms (7) · Neuroectodermal Tumors (7) · Neoplasms, Neuroepithelial (6) · Central Nervous System Neoplasms (2) · Glioma (2) · Neoplastic Processes (2)
Temozolomide (3) · Chlorotoxin (2) · Arsenic Trioxide (1) · Carmustine (1) · Ethanol (1) · Metabolism (1) · Radiotherapy (1) · Verteporfin (1) · lonafarnib (1)
European Organisation for Research and Treatment of Cancer - EORTC (2) · TransMolecular (2) · Direct Therapeutics (1) · Medical College of Wisconsin (1) · Northwestern University (1)
United States (5) · France (1) · Switzerland (1) · United Kingdom (1)
Jeffrey Raizer, MD (2) · Sean Grimm, MD (2) · Adam Mamelak, MD (1) · Antonio Omuro, MD (1) · Burt Nabors, MD (1) · David Schiff, MD (1) · Edward Pan, MD (1) · Gene David Resnick, MD (1) · Gerry Linette, MD (1) · Glenn Lesser, MD (1) · Harry T. Whelan, MD (1) · Heather Jacene, MD (1) · Jan Drappatz, MD (1) · Jay-Jiguang Zhu, MD (1) · Jeffrey Olson, MD (1)